Opinion: Help pharmacists fulfill the goals of 'test to treat'

During the State of the Union address, President Biden announced the “test to treat” initiative to allow patients to get tested for the coronavirus at pharmacies and, if positive, receive oral antiviral pills immediately at no cost [”White House ‘test to treat’ plan garners praise, raises questions,” Politics & the Nation, March 5]. This is an important acknowledgment of pharmacy accessibility and capability, and I commend the administration’s recognition of pharmacy and its value to public health. As we now know, timely testing and treatment are essential to curb the spread and reduce hospitalizations. Though this initiative is a positive step forward, we must address the legislative hurdles that will challenge the long-term viability of the “test to treat” model.

For the full article, click here.